U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H2N4O.2Na
Molecular Weight 180.0751
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYPOXANTHINE DISODIUM

SMILES

[Na+].[Na+].O=C1[N-]C=NC2=C1N=C[N-]2

InChI

InChIKey=JPOVYURXCDZDIC-UHFFFAOYSA-M
InChI=1S/C5H3N4O.2Na/c10-5-3-4(7-1-6-3)8-2-9-5;;/h1-2H,(H-,6,7,8,9,10);;/q-1;2*+1/p-1

HIDE SMILES / InChI

Molecular Formula C5H2N4O
Molecular Weight 134.0956
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26196868 | https://www.ncbi.nlm.nih.gov/pubmed/17149876 | https://www.ncbi.nlm.nih.gov/pubmed/25956679 | https://www.ncbi.nlm.nih.gov/pubmed/28238512 | https://www.ncbi.nlm.nih.gov/pubmed/3670521

Hypoxanthine is a naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. Hypoxanthine is a necessary additive in the certain cell, bacteria, and parasite cultures as a substrate and nitrogen source. For example, it is commonly a required reagent in malaria parasite cultures, since Plasmodium falciparum requires a source of hypoxanthine for nucleic acid synthesis and energy metabolism.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Off-pump versus on-pump coronary artery bypass grafting: oxidative stress and renal function.
2001-11
Inhibitory effects of methylxanthines on the pre-eclamptic-like symptoms in ewes.
2001-11
Catabolism of exogenous deoxyinosine in cultured epithelial amniotic cells.
2001-10-03
Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells.
2001-10
Addition of hypoxanthine to culture media allows in vitro cultivation of Babesia bovis and B. bigemina at reduced serum concentrations.
2001-10
Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.
2001-10
Effects of storage temperature and preservative treatment on shelf life of the pond-raised freshwater fish, silver perch (Bidyanus bidyanus).
2001-10
Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol.
2001-10
Sperm disposal system in spermatic granuloma: a link with superoxide radicals.
2001-10
DNA triple-helix formation at pyrimidine-purine inversion sites.
2001-09-21
[Biochemical parameters predictive of neuronal damage in childhood].
2001-09-20
Molecular analysis of HPRT1(+) somatic cell hybrids derived from a carrier of an HPRT1 mutation responsible for Lesch-Nyhan syndrome.
2001-09-15
Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings.
2001-09-03
Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis.
2001-09
Early onset of lipid peroxidation after human traumatic brain injury: a fatal limitation for the free radical scavenger pharmacological therapy?
2001-09
Newborn piglets with meconium aspiration resuscitated with room air or 100% oxygen.
2001-09
Protein kinase C, rather than protein kinase A is involved in follicle-stimulating hormone-mediated meiotic resumption of mouse cumulus cell-enclosed oocytes in hypoxanthine-supplemented medium.
2001-09
L-tyrosine and nitric oxide synergize to prevent cytotoxic effects of superoxide.
2001-08-28
Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo.
2001-08-03
Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum.
2001-08-01
Unaltered apoptotic behaviour of mononuclear cells from patients with sporadic Creutzfeldt-Jakob disease.
2001-08
Isolation and characterization of the Xanthine dehydrogenase gene of the Mediterranean fruit fly, Ceratitis capitata.
2001-08
Pyruvate improves cerebral metabolism during hemorrhagic shock.
2001-08
Investigation of the functional role of active site loop II in a hypoxanthine phosphoribosyltransferase.
2001-07-27
[Post-radiation changes in kinetic parameters of purine-catabolizing enzymes in rat blood serum after combined action of external and internal irradiation caused by 137Cs].
2001-07-19
[Polymethylene derivatives of nucleic bases with omega-functional groups. II. Adenine and hypoxanthine derivatives].
2001-07-11
Study of the interaction of cis-dichloro-(1,2 diethyl-3-aminopyrrolidine)Pt(II) complex with poly(I), poly(C) and poly(I) x poly(C).
2001-07
Random amplified ribosomal DNA restriction analysis for rapid identification of thermophilic Actinomycete-like bacteria involved in hypersensitivity pneumonitis.
2001-07
The effect of allopurinol on focal cerebral ischaemia: an experimental study in rabbits.
2001-07
Separation of inosine, hypoxanthine, and guanosine by high-performance liquid chromatography on silica.
2001-07
In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity.
2001-07
Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography.
2001-07
Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries.
2001-07
Sudden infant death syndrome Part 2: the response of the reticuloendothelial system to hypoxemia and infection.
2001-07
Purine salvage to adenine nucleotides in different skeletal muscle fiber types.
2001-07
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.
2001-06-26
Superoxide potently induces ceramide formation in glomerular endothelial cells.
2001-06-08
Antiplasmodial and antioxidant isofuranonaphthoquinones from the roots of Bulbine capitata.
2001-06
Altered purine nucleotide degradation during exercise in patients with essential hypertension.
2001-06
Changes in serum hypoxanthine levels by exercise in obese subjects.
2001-06
Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs.
2001-05-15
[Two cases of exercise-induced acute renal failure with idiopathic renal hypouricemia].
2001-05
Adenine deaminase activity of the yicP gene product of Escherichia coli.
2001-05
Oxidative stress impairs insulin internalization in endothelial cells in vitro.
2001-05
Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria.
2001-04
Sudden infant death syndrome (SIDS): T-cell immunodeficiency--Part 1.
2001-02
Protection of the rat liver against rewarming ischemic injury by University of Wisconsin solution.
2001-02
Is skeletal muscle damaged by the oxidative stress following anaerobic exercise?
2001
The mechanism of switching among multiple BER pathways.
2001
Base excision repair in nuclear and mitochondrial DNA.
2001
Patents

Patents

Sample Use Guides

2 μL of a solution of hypoxanthine (20 pmol/2 μL) or vehicle (saline 0.9 %) was administered in the right striatum of the rats 1 μL per minute.
Route of Administration: Other
The in vitro drug sensitivity of the Cambodian isolates was assessed by use of a classical isotopic 48- h test. fresh blood samples were washed three times with RPMI 1640 medium (GibcoTM, Invitrogen Corporation, France) by centrifugation (800×g, 10 min). The parasites were then tested directly without culture adaptation. The infected erythrocytes (1.5% hematocrit, 0.1–1% parasitemia) were suspended in complete RPMI medium supplemented with 10% of decomplemented human AB+ serum (Biomedia, France) and buffered with 25 mM/l Hepes and 25 mM/l NaHCO3. The mixture was distributed (200 mkl per well) into the 96-well test plates that had been pre-coated with antimalarial agents. Each plate included two drug-free control wells and one control well without parasites. The culture plates were incubated for 48 h at 37 ◦Cina5%CO2 atmosphere. [3H]Hypoxanthine (0.5 mkCi/well; Amersham Biosciences, France) was used to assess parasite growth. Each isolate was tested once in duplicate in the microplates with serial dilutions of drugs. Drug response was quantified by monitoring [3H]hypoxanthine uptake in aWallac MicroBeta Trilux counter (Perkin-Elmer, France). At the end of the incubation period, the plates were frozen at −20 ◦C and thawed to lyse the cells. After collection on glassfiber filter paper using a cell harvester, the amount of [3H]hypoxanthine incorporated into the parasites nucleoprotein was determined.
Substance Class Chemical
Created
by admin
on Tue Apr 01 21:44:35 GMT 2025
Edited
by admin
on Tue Apr 01 21:44:35 GMT 2025
Record UNII
T9NOU36NPS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
6H-PURIN-6-ONE, 1,9-DIHYDRO-, SODIUM SALT (1:2)
Preferred Name English
HYPOXANTHINE DISODIUM
Common Name English
DISODIUM 6-OXO-6H-PURINE-3,7-DIIDE
Common Name English
HYPOXANTHINE, DISODIUM SALT
Common Name English
Code System Code Type Description
PUBCHEM
44119334
Created by admin on Tue Apr 01 21:44:35 GMT 2025 , Edited by admin on Tue Apr 01 21:44:35 GMT 2025
PRIMARY
CAS
199329-61-8
Created by admin on Tue Apr 01 21:44:35 GMT 2025 , Edited by admin on Tue Apr 01 21:44:35 GMT 2025
PRIMARY
FDA UNII
T9NOU36NPS
Created by admin on Tue Apr 01 21:44:35 GMT 2025 , Edited by admin on Tue Apr 01 21:44:35 GMT 2025
PRIMARY